+91-8668442535

Diabetes Injection Pens Market By Indication (Type I Diabetes, Type Ii Diabetes), By Product Type (Insulin Pens, Insulin Pen Needles), By Form (Disposable, Reusable) - Growth, Future Prospects And Competitive Analysis 2017 – 2025

The purpose of this research study titled "Diabetes Injection Pens Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global diabetes injection pens market.

This report presents and analyses the major trends prevalent in the global market for diabetes injection pens, as well as the market's size and forecast.

This report categorizes the global diabetes injection pens market in terms of diabetes type, product type, form, and geographical distribution. The global market for diabetes injection pens is divided into two types: type I and type II diabetes.Insulin pens and insulin pen needles are the major product types considered in this study.

Furthermore, studies of disposable and reusable forms of diabetes injection pens are also included in this report. The market size and forecast for each mentioned segment for the period 2015–2025 are presented in the report, along with respective CAGRs for the forecast duration of 2017–2025.

Geographically, the global market for diabetes injection pens is best understood by segmenting the market into five major regions and five major region-level markets, which are as follows:

  • North America
  • U.S.
  • Canada
  • Europe
  • EU 7
  • CIS
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • rest of Latin America
  • Middle East and Africa
  • GCC
  • Rest of the Middle East and Africa

This study presents the market size and forecast for each considered geographical market for the period 2015-2025, as well as CAGRs for the forecast period 2017-2025, and is further cross-sectionally presented in terms of diabetes type, product type, form, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global diabetes injection pens market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study.

Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the diabetes injection pens market. The key players profiled in this report are AstraZeneca plc, Becton, Dickinson and Company, Biocon Ltd., Eli Lilly and Company, Jiangsu Delfu Co., Novo Nordisk A/S, Owen Mumford Ltd., and Wockhardt Ltd.

The global diabetes injection pen market is studied for the following segments:

Indication

  • Type I diabetes
  • Type II diabetes

Product Type

  • Insulin Pens
  • Needles for Insulin Pens

Form     

  • Disposable
  • Reusable

Injection pens are seen being used in both types I and type II patients. Between these patient groups, type II diabetes acquires the larger revenue share due to the large patient population belonging to this condition. In addition, since type II diabetes occurs most commonly in adult individuals, rational insulin administration through injection pens is highly prevalent.

The growing patient base of children with type II diabetes, on the other hand, presents a lucrative penetration opportunity for manufacturers of diabetes injection pens. Based on injection forms, this market is categorized into disposable and reusable injection pens. Both disposable and reusable forms of diabetes injection pens are nearly equally used among patients worldwide.

Reusable pens, on the other hand, appear to be more popular in developed markets. It is anticipated that the same trend will continue through the forecast period, with a higher preference for disposable injection forms in developing economies.

The global market for diabetes injection pens spans North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America.

Among the considered regional markets, North America and Europe together occupy the largest revenue share of the global diabetes injection pen market. In North America and globally, the United States captures the largest revenue share. The dominance of the United States is attributed to its large diabetic population, better reimbursement system, and healthcare awareness about the treatment and management of diabetes.

The European market, on the other hand, is said to be saturated and will grow at an average rate. Furthermore, Asia Pacific is anticipated to be the fastest-growing regional market for diabetes injection pens. Growing awareness and the increased ability of patients to pay for advanced medicine are the key driving factors for the Asia Pacific diabetes injection pen market.

The detailed regional classification of the global diabetes injection pen market is as follows:

  • North America (U.S. and Canada)
  • Europe (EU 7, CIS, and Other European Countries)
  • Asia Pacific (China, India, and the Rest of Asia Pacific)
  • Middle East and Africa (GCC plus the rest of the Middle East and Africa)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)

Frequently Asked Question:

The market for Diabetes Injection Pens Market is expected to reach USD$ 10.7 Mn in 2025.

The Diabetes Injection Pens Market is expected to see significant CAGR growth over the coming years, at 7.2%.

The report is forecasted from 2017 -2025.

The base year of this report is 2016.

AstraZeneca plc, Becton, Dickinson and Company, Biocon Ltd., Eli Lilly and Company, Jiangsu Delfu Co., Novo Nordisk A/S, Owen Mumford Ltd. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  May 2017
Category:  Medical Devices
Report ID:   58476
Report Format:   PDF
Pages:   120
Rating:    4.7 (65)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support